Advertisement

Angeborene Fehlbildungen und Dysmorphiesyndrome

  • Gholamali Tariverdian
  • Marion Paul
Chapter
  • 23 Downloads

Zusammenfassung

Kongenitale Fehlbildungen sind die Folge einer gestörten bzw. unvollständigen Embryogenese. Störungen in allen Entwicklungsstadien (Tabelle 9.1) können zu morphologischen Anomalien führen. Sie können einzeln oder in multipler Form auftreten.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aase J (1990) Diagnostic dysmorphology. Plenum, LondonGoogle Scholar
  2. Baraitser M, Winter RM (1991) London Neurogenetics Database. A valuable computerized database of neurogenetic disorders. Oxford University PressGoogle Scholar
  3. Belloni E, Muenke M, Roessler E et al. (1996) Identification of sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 14:353–356PubMedCrossRefGoogle Scholar
  4. Bergsma DS (1979) Birth defects atlas and compendium, 2nd edn. Williams & Wilkins, BaltimoreGoogle Scholar
  5. Böhler T, Buchholz B (1998) HIV-Infektion des Neugeborenen. In: Friese K, Kachel W (Hrsg) Infektionserkrankungen der Schwangeren und des Neugeborenen, 2. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  6. Brettle RP, Raab GM, Rossa A et al. (1995) HIV infection in women: immunological markers and the influence of pregnancy. AIDS 9:1177–1184PubMedCrossRefGoogle Scholar
  7. Brown KE, Young NS (1997) Human parvovirus B19: pathogenesis of disease. In: Anderson LJ, Young NS (eds) Human parvovirus B19. Karger, Basel, pp 105–119 (Monogr Virol)CrossRefGoogle Scholar
  8. Brueton LA, Winter RM (1993) Molecular aspects of morphogenesis. Bailliere’s Clin Paediat 1:345–373Google Scholar
  9. Buehler BA, Delimont D, van Waes M et al. (1990) Prenatal prediction at risk of the fetal hydantoin syndrome. N Engl J Med 322:1567–1572PubMedCrossRefGoogle Scholar
  10. Connor JM, Ferguson-Smith (1993) Essential medical genetics, 3rd edn. Blackwell, OxfordGoogle Scholar
  11. Cooper LZ, Preblud SR, Alford CA (1995) Rubella. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 4th edn. Saunders, Philadelphia, pp 268–311Google Scholar
  12. Dean M (1996) Polarity, proliferation and the hedgehog pathway. Nat Genet 14:245–247PubMedCrossRefGoogle Scholar
  13. Demmler GJ (1991). Infectious disease society of America and Centers of Disease Control - Summary on a workshop of surveillance for congenital cytomegalovirus disease. Rev Infect Dis 13:315–329PubMedCrossRefGoogle Scholar
  14. Demmler GJ (1996) Congenital cytomegalovirus infection and disease. Adv Pediat Infect Dis 11:135–162Google Scholar
  15. Dirmeier D, Arents A, Schalasta G, Meier S, Enders G (1997, in print) Prenatal diagnosis of rubella virus infection detected by polymerase chain reaction in fetal samples. Clin Diagn VirolGoogle Scholar
  16. Dobbins JG, Stewart JA, Demmler GJ (1992) Surveillance of congenital cytomegalovirus disease 1990–1991. Centers for Disease Control, Morbidity and Mortality. Weekly Report 41:35–39Google Scholar
  17. Donner C, Liesnard C, Brancart F et al. (1994) Accuracy of amniotic fluid testing before 21 weeks gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn 14:1055–1059PubMedCrossRefGoogle Scholar
  18. El Ghouzzi V, LeMerrer M, Perrin-Schmitt F et al. (1997) Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15:42–46PubMedCrossRefGoogle Scholar
  19. Enders G (1988) Infektionen und Impfungen in der Schwangerschaft. Urban & Schwarzenberg, MünchenGoogle Scholar
  20. Enders G (1994) Röteln, Zytomegalie und Ringelröteln. In: Friese K, Kachel W (Hrsg) Infektionskrankheiten der Schwangeren und des Neugeborenen. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  21. Enders G (1998) Röteln und Ringelröteln. In: Friese K, Kachel W (Hrsg) Infektionserkrankungen der Schwangeren und des Neugeborenen, 2. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  22. Enders G, Biber M (1990) Ringelröteln: Probleme und Diagnostik. Ärztl Praxis 72:14–15Google Scholar
  23. Enders G, Miller E, Cradock-Watson J et al. (1994) Consequences of varicella and herpes zoster in pregnancy. Prospective study of 1739 cases. Lancet 343:1547–1550CrossRefGoogle Scholar
  24. European Collaborative Study (1992) Risk factors for mother-to-child transmission of HIV-1. Lancet 339:1007–1012CrossRefGoogle Scholar
  25. European Collaborative Study (1996) Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 10:1675–1681Google Scholar
  26. European Collaborative Study (1998) Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br J Obstet Gynaecol 105:704–709CrossRefGoogle Scholar
  27. Fabel G (1998) Medikation in Schwangerschaft und Stillzeit, 2. Aufl. Urban & Schwarzenberg, MünchenGoogle Scholar
  28. Fowler KB, Stagno S, Pass RF et al. (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326:663–667PubMedCrossRefGoogle Scholar
  29. Friese K, Enders G (1998) Zytomegalie, Varizellen und Herpes. In: Friese K, Kachel W (Hrsg) Infektionserkrankungen der Schwangeren und des Neugeborenen, 2. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  30. Friese K, Kachel W (Hrsg) (1998) Infektionserkrankungen der Schwangeren und des Neugeborenen, 2. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  31. Gorlin RJ, Cohen MM Jr, Lewin LS (1990) Syndromes of the head and neck, 3rd edn. Oxford University PressGoogle Scholar
  32. Grillner L, Forsgren M, Barr B et al. (1983) Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scand J Infect Dis 15:321–325PubMedGoogle Scholar
  33. Hall JG (1984) Vitamin A: a newly recognized human tertogen. Harbinger of things to come? J Pediatr 105:583–584PubMedCrossRefGoogle Scholar
  34. Hall JG, Pauli RM, Wilson KM (1980) Maternal and fetal of sequelae of anticoagulants during pregnancy. Am J Med 68:122–140PubMedCrossRefGoogle Scholar
  35. Hammer EJ (1985) Retinoic acid embryopathy. N Engl J Med 313:837–841CrossRefGoogle Scholar
  36. Hanson JW, Buchler BA (1982) Fetal hydantoin syndrome: current status. J Pediat lot: 816–818Google Scholar
  37. Harris JW (1992) Parvovirus B 19 for hematologists. Am J Hematol 39:119–130PubMedCrossRefGoogle Scholar
  38. Hlobil H, Friese K (1998) Pränatale Toxoplasmose. In: Friese K, Kachel W (Hrsg) Infektionskrankheiten der Schwangeren und des Neugeborenen, 2. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  39. Hohlfeld P, Daffos F, Cost JM et al. (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 331: 695–699PubMedCrossRefGoogle Scholar
  40. Istas AS, Demmler GJ, Dobbins JG, Stewart JA (1995) Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis 20:665–670PubMedCrossRefGoogle Scholar
  41. Janischke K (1994) Stand der Serodiagnostik der Toxoplasmoseinfektion in der Schwangeren-und Kindervorsorge. In: Pohle HD, Remington JS (Hrsg) Toxoplasmoseerreger und Krankheit. SM, GräfelfingGoogle Scholar
  42. Janz DL, Bossi M, Dam H et al. (eds) (1982) Epilepsy, pregnancy, and the child. Raven, New YorkGoogle Scholar
  43. Jones KL (1997) Smith’s recognisable patterns of human malformations, 4th edn. Saunders, PhiladelphiaGoogle Scholar
  44. Kreß W, Collmann H, Zeitler P et al. (1996) Kraniosynostosen - Widerspruch zwischen Genotyp und Phänotyp? Med Genet 4:310–313Google Scholar
  45. Leiber B, Olbrich G (1981) Die Klinischen Syndrome. Urban & Schwarzenberg, MünchenGoogle Scholar
  46. Lenz W (1983) Medizinische Genetik, 6. Aufl. Thieme, StuttgartGoogle Scholar
  47. Lewanda AF, Cohen MM Jr, Jackson CE et al. (1994) Genetic heterogeneity among craniosynostosis syndromes: mapping the Saethre-Chotzen syndrome locus between D7S518 and D7S516 and exclusion of Jackson-Weiss and Crouzon syndrome loci from 7p. Genomics 19:115–119PubMedCrossRefGoogle Scholar
  48. Lindhout D, Meinradi H, Barth PG (1982) Hazard of fetal exposure to drug combination. In: Janz DL et al. (eds) Epilepsy, pregnancy, and the child. Raven, New York, pp 275–280Google Scholar
  49. Majewski F (1978) Zur Häufigkeit und Pathogenese der Alkoholembryopathie. Mschr Kinderheilkd 126:284Google Scholar
  50. McGinnis W, Krumlauf R (1992) Homeobox genes and axial patterning. Cell 68:283–302PubMedCrossRefGoogle Scholar
  51. Miller E, Cradock-Watson JE, Pollock JM (1982) Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet II:781–784CrossRefGoogle Scholar
  52. Milunsky A (ed) (1986) Genetic disorders and the fetus, 2nd edn. Plenum, New YorkGoogle Scholar
  53. Moloney M, Slaney SF, Oldbridge M et al. (1996) Exclusive paternal origin of new mutations in Apert’s syndrome. Nat Genet 13:48–53PubMedCrossRefGoogle Scholar
  54. Muenke M (1989) Clinical, cytogenetic and molecular approaches to the genetic heterogeneity of holoprosencephaly. Am J Hum Genet 34:237–245Google Scholar
  55. Muenke M (1997) A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 60:555–564PubMedGoogle Scholar
  56. Muenke M, Schell U (1995) Fibroblast growth factor receptor mutations in human skeletal disorders. Trends Genet 11:308–313PubMedCrossRefGoogle Scholar
  57. Muenke M, Schell U, Hehr A et al. (1994) A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer’s syndrome. Nat Genet 8:269–274PubMedCrossRefGoogle Scholar
  58. Nigro G, Clerico A, Mandaini C (1993) Symptomatic congenital cytomegalovirus infection in two consecutive sisters. Arch Dis Child 69:527–528PubMedCrossRefGoogle Scholar
  59. OSSUM: An illustrated database of skeletal dysplasias. C.P. Export Pty. Ltd., 613 St. Kilda Road, Melbourne 3004, Victoria/AustraliaGoogle Scholar
  60. Pass RF, Fowler KB, Boppana SB (1991) Progress in cytomegalovirus research. In: Proceedings of the third international cytomegalovirus workshop, Bologna, Italy, June 1991. Landini, London (Excerpta Medica, pp 3–10)Google Scholar
  61. POSSUM: Pictures of standard syndromes and undiagnosed malformations. C.P. Export Pty. Ltd., 613 St. Kilda Road, Melbourne 3004, Victoria/AustraliaGoogle Scholar
  62. Preblud SR, Alford CA (1990) Rubella. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and new born infant, 3rd edn. Saunders, Philadelphia, pp 196–240Google Scholar
  63. Preiser W (1996) Impfungen in der Schwangerschaft. TW Gynäkologie 9:425–435Google Scholar
  64. Public Health Laboratory Service Working Party on Fifth Disease (1990) Prospective study of human parvovirus B 19 infection in pregnancy. BMJ 300:1166–1170CrossRefGoogle Scholar
  65. Radhakrishna U, Wild A, Grzeschik KH et al. (1997) Mutation in GLI3 in postaxial polydactyly type A. Nat Genet 17:1269–1271CrossRefGoogle Scholar
  66. Reardon W et al. (1997) Craniosynostosis associated with FGFR3 pro 250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis. J Med Genet 34:632–636PubMedCrossRefGoogle Scholar
  67. Rimoin DL, Connor JM, Pyeritz RE (eds) (1997) Emery and Rimoin’s principles and practice of medical genetics, 3rd edn. Churchill Livingstone, EdinburghGoogle Scholar
  68. Schäfer APA (1996) Die HIV-Infektion in Geburtshilfe und Gynäkologie. Gynäkologe 29:129–137Google Scholar
  69. Schäfer H, Friese K (1998) HIV-Infektion der Schwangeren. In: Friese K, Kachel W (Hrsg) Infektionserkrankungen der Schwangeren und des Neugeborenen, 2. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  70. Schwarz TF, Roggendorf M, Hottenträger B et al. (1988) Human parvovirus B 19 infection in pregnancy. J Exp Clin Chemother 3:219–223Google Scholar
  71. Shepard TH (1992) Catalog of teratogenic agents, 7th edn. Johns Hopkins University Press, BaltimoreGoogle Scholar
  72. Slack JMW (1991) From egg to embryo, 2nd edn. Cambridge University PressCrossRefGoogle Scholar
  73. Sperling K, Pelz J, Wegner RD et al. (1994) Significant increase in trisomy 21 in Berlin nine month after the Chernobyl reactor accident: temporal correlation or causal relation? Basisrisiko Med J 309:158–162CrossRefGoogle Scholar
  74. Spielmann H, Steinhoff R, Schaefer C, Bunjes R (1998) Arzneiverordnung in Schwangerschaft und Stillzeit. G. Fischer, StuttgartGoogle Scholar
  75. Spranger J, Langer LO, Wiedemann HR (1974) Bone dysplasias, an atlas of constitutional disorders of skeletal development. Saunders, PhiladelphiaGoogle Scholar
  76. Spranger J, Bernischke K, Hall JC et al. (1982) Errors of morphogenesis: concepts and terms. Recommendations of an international working group. J Pediat 100:160–165PubMedCrossRefGoogle Scholar
  77. Stagno S (1992) Cytomegalovirus. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. Saunders, Philadelphia, pp 312–353Google Scholar
  78. Tariverdian G (1995) Fehlbildungs-und Dysmorphiesyndrome. In: Sohn C, Holzgreve W (Hrsg) Ultraschall in Gynäkologie und Geburtshilfe. Thieme, Stuttgart, S 465–474Google Scholar
  79. Temtamy SA, McKusick VA (1978) The genetics of hand malformations. Liss, New York (Birth Defects Original Article Series XIV)Google Scholar
  80. Tercanli S, Enders G, Holzgreve W (1996) Aktuelles Management bei mütterlichen Infektionen mit Röteln, Toxoplasmose, Zytomegalie, Varizellen und Parvovirus B 19 in der Schwangerschaft. Gynäkologe 29:144Google Scholar
  81. Unscear Report (1982) Ionizing radiation. Sources and biological effects. Annex 1: Genetic effects of radiation. United Nations, New YorkGoogle Scholar
  82. Warkany J (1971) Congenital malformations. Year Book Medical Publishers, ChicagoGoogle Scholar
  83. Webster MK, Donoghue DJ (1997) FGFR activations in sceletal disorders: too much of a good thing. Trends Genet 13:178–182PubMedCrossRefGoogle Scholar
  84. Whittle MJ, Rubin PC (1989) Exposure to teratogens. In: Whittle MJ, Connor JM (eds) Prenatal diagnosis in obstetric practice. Blackwell, Oxford, pp 161–167Google Scholar
  85. Wilkie AOM (1997) Craniosynostosis: genes and mechanisms. Hum Mol Genet 6:1647–1656PubMedCrossRefGoogle Scholar
  86. Winter RM, Baraitser M (1991) London Dysmorphology Database. Oxford University PressGoogle Scholar
  87. Winter RM, Baraitser M (1991) Multiple congenital anomalies. Chapman & Hall, LondonGoogle Scholar
  88. Wolf U (1995) The molecular genetics of human sex determination. J Mol Med 73:325–331PubMedCrossRefGoogle Scholar
  89. Wynne-Davies R (1987) Skeletal dysplasias. Basisrisiko Med J 295:685–686CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Gholamali Tariverdian
    • 1
  • Marion Paul
    • 2
  1. 1.Institut für Humangenetik der Universität Heidelberg Genetische PoliklinikHeidelbergGermany
  2. 2.Gemeinschaftspraxis Drs. med. M. Paul, M. Chwat, M. GastMannheimGermany

Personalised recommendations